Planar myocardial perfusion imaging with technetium-99m-teboroxime: Comparison by vascular territory with thallium-201 and coronary angiography

S. T. Dahlberg, H. Weinstein, Robert Hendel, B. McSherry, J. A. Leppo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Myocardial perfusion agents labeled with 99mTc offer improved physical imaging properties compared to 201Tl. Teboroxime is a new 99mTc-labeled compound for myocardial perfusion imaging that shows a high myocardial extraction and rapid clearance. Sixty-seven patients underwent planar teboroxime imaging with a rapid acquisition protocol. Agreement of teboroxime and 201Tl for the presence or absence of disease occurred in 56/65 patients (86%). There was agreement (normal or abnormal) between the two agents in 156/195 vessels (80%) and 457/585 segments (78%). When abnormal segments (ischemia or infarction) were compared, teboroxime showed significantly more ischemic segments (89/135, 66%) than did 201Tl (73/135, 54%, p < 0.05). Teboroxime offers accuracy comparable to 201Tl for the diagnosis of coronary artery disease and may improve the detection of ischemic or viable myocardium. In addition, its rapid myocardial clearance permits stress/rest imaging in 60-90 min.

Original languageEnglish
Pages (from-to)1783-1788
Number of pages6
JournalJournal of Nuclear Medicine
Volume33
Issue number10
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Myocardial Perfusion Imaging
Thallium
Technetium
Coronary Angiography
Blood Vessels
Infarction
Coronary Artery Disease
Myocardium
Ischemia
Perfusion
technetium Tc 99m teboroxime

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Planar myocardial perfusion imaging with technetium-99m-teboroxime : Comparison by vascular territory with thallium-201 and coronary angiography. / Dahlberg, S. T.; Weinstein, H.; Hendel, Robert; McSherry, B.; Leppo, J. A.

In: Journal of Nuclear Medicine, Vol. 33, No. 10, 01.01.1992, p. 1783-1788.

Research output: Contribution to journalArticle

Dahlberg, S. T. ; Weinstein, H. ; Hendel, Robert ; McSherry, B. ; Leppo, J. A. / Planar myocardial perfusion imaging with technetium-99m-teboroxime : Comparison by vascular territory with thallium-201 and coronary angiography. In: Journal of Nuclear Medicine. 1992 ; Vol. 33, No. 10. pp. 1783-1788.
@article{23a3e1687a124362b2ea499f26cf451d,
title = "Planar myocardial perfusion imaging with technetium-99m-teboroxime: Comparison by vascular territory with thallium-201 and coronary angiography",
abstract = "Myocardial perfusion agents labeled with 99mTc offer improved physical imaging properties compared to 201Tl. Teboroxime is a new 99mTc-labeled compound for myocardial perfusion imaging that shows a high myocardial extraction and rapid clearance. Sixty-seven patients underwent planar teboroxime imaging with a rapid acquisition protocol. Agreement of teboroxime and 201Tl for the presence or absence of disease occurred in 56/65 patients (86{\%}). There was agreement (normal or abnormal) between the two agents in 156/195 vessels (80{\%}) and 457/585 segments (78{\%}). When abnormal segments (ischemia or infarction) were compared, teboroxime showed significantly more ischemic segments (89/135, 66{\%}) than did 201Tl (73/135, 54{\%}, p < 0.05). Teboroxime offers accuracy comparable to 201Tl for the diagnosis of coronary artery disease and may improve the detection of ischemic or viable myocardium. In addition, its rapid myocardial clearance permits stress/rest imaging in 60-90 min.",
author = "Dahlberg, {S. T.} and H. Weinstein and Robert Hendel and B. McSherry and Leppo, {J. A.}",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "33",
pages = "1783--1788",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "10",

}

TY - JOUR

T1 - Planar myocardial perfusion imaging with technetium-99m-teboroxime

T2 - Comparison by vascular territory with thallium-201 and coronary angiography

AU - Dahlberg, S. T.

AU - Weinstein, H.

AU - Hendel, Robert

AU - McSherry, B.

AU - Leppo, J. A.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Myocardial perfusion agents labeled with 99mTc offer improved physical imaging properties compared to 201Tl. Teboroxime is a new 99mTc-labeled compound for myocardial perfusion imaging that shows a high myocardial extraction and rapid clearance. Sixty-seven patients underwent planar teboroxime imaging with a rapid acquisition protocol. Agreement of teboroxime and 201Tl for the presence or absence of disease occurred in 56/65 patients (86%). There was agreement (normal or abnormal) between the two agents in 156/195 vessels (80%) and 457/585 segments (78%). When abnormal segments (ischemia or infarction) were compared, teboroxime showed significantly more ischemic segments (89/135, 66%) than did 201Tl (73/135, 54%, p < 0.05). Teboroxime offers accuracy comparable to 201Tl for the diagnosis of coronary artery disease and may improve the detection of ischemic or viable myocardium. In addition, its rapid myocardial clearance permits stress/rest imaging in 60-90 min.

AB - Myocardial perfusion agents labeled with 99mTc offer improved physical imaging properties compared to 201Tl. Teboroxime is a new 99mTc-labeled compound for myocardial perfusion imaging that shows a high myocardial extraction and rapid clearance. Sixty-seven patients underwent planar teboroxime imaging with a rapid acquisition protocol. Agreement of teboroxime and 201Tl for the presence or absence of disease occurred in 56/65 patients (86%). There was agreement (normal or abnormal) between the two agents in 156/195 vessels (80%) and 457/585 segments (78%). When abnormal segments (ischemia or infarction) were compared, teboroxime showed significantly more ischemic segments (89/135, 66%) than did 201Tl (73/135, 54%, p < 0.05). Teboroxime offers accuracy comparable to 201Tl for the diagnosis of coronary artery disease and may improve the detection of ischemic or viable myocardium. In addition, its rapid myocardial clearance permits stress/rest imaging in 60-90 min.

UR - http://www.scopus.com/inward/record.url?scp=0026783008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026783008&partnerID=8YFLogxK

M3 - Article

C2 - 1403145

AN - SCOPUS:0026783008

VL - 33

SP - 1783

EP - 1788

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 10

ER -